ERBB2 and neoplasm: Five different QDs (QD525, QD565, QD605, QD655, QD705) conjugated with antibodies against HER2, ER, PR, EGFR, and mTOR biomarkers, respectively, were used for multiplexed detection of these antigens in breast cancer cells (MCF-7 and BT474 cell lines) and in tumour biopsy specimens.